Avalo Therapeutics (AVTX) Revenue (2016 - 2025)
Avalo Therapeutics (AVTX) posted Revenue of $59000.0 for Q4 2025, down 69.27% on a QoQ basis from $192000.0 in Q4 2024, and down 69.27% year-over-year from $192000.0 in Q4 2024.
Avalo Therapeutics (AVTX) Revenue (2016 - 2025) Analysis & Trends
Avalo Therapeutics' Revenue history runs 10 years deep, the most recent figure standing at $59000.0 for Q4 2025.
- Quarterly Revenue fell 69.27% year-over-year to $59000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $500000.0 (up 13.38% YoY) and the FY2025 annual result came in at $59000.0, down 86.62% from the prior year.
- Revenue was $59000.0 for Q4 2025 at Avalo Therapeutics, down from $192000.0 in the prior quarter.
- Across five years, Revenue topped out at $14.9 million in Q3 2022 and bottomed at $59000.0 in Q4 2025.
- A 5-year average of $1.7 million and a median of $571000.0 in 2023 frame the typical range for Revenue.
- Annual changes were most pronounced in 2022 — Revenue surged 1007.33% — and 2023, when it plunged 98.42%.
- Avalo Therapeutics' Revenue stood at $219000.0 in 2021, then jumped by 309.13% to $896000.0 in 2022, then slumped by 36.27% to $571000.0 in 2023, then plunged by 66.37% to $192000.0 in 2024, then sank by 69.27% to $59000.0 in 2025.
- Business Quant data shows AVTX's Revenue at $59000.0 in Q4 2025, $192000.0 in Q4 2024, and $249000.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 1.51 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 2.99 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 3.61 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 1.30 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Avalo Therapeutics | 371.17 Mn | 371.17 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 59,000.00 |
| Dec 31, 2024 | 192,000.00 |
| Sep 30, 2024 | 249,000.00 |
| Dec 31, 2023 | 571,000.00 |
| Sep 30, 2023 | 236,000.00 |
| Jun 30, 2023 | 643,000.00 |
| Mar 31, 2023 | 475,000.00 |
| Dec 31, 2022 | 896,000.00 |
| Sep 30, 2022 | 14.95 Mn |
| Jun 30, 2022 | 1.03 Mn |
| Mar 31, 2022 | 1.17 Mn |
| Dec 31, 2021 | 219,000.00 |
| Sep 30, 2021 | 1.35 Mn |
| Jun 30, 2021 | 3.36 Mn |
| Mar 31, 2021 | 473,000.00 |
| Dec 31, 2020 | 1.50 Mn |
| Sep 30, 2020 | 1.11 Mn |
| Jun 30, 2020 | 1.34 Mn |
| Mar 31, 2020 | 2.75 Mn |
| Dec 31, 2019 | 4.00 Mn |